151 related articles for article (PubMed ID: 3003299)
1. The responses of adrenocorticotrophic hormone and cortisol to insulin-induced hypoglycaemic stress in man are unimpaired during chronic converting enzyme inhibition.
Morganti A; Ambrosi B; Sala C; Bochicchio D; Turolo L; Cianci L; Checchini M; Zanchetti A
J Hypertens Suppl; 1985 Nov; 3(2):S121-4. PubMed ID: 3003299
[TBL] [Abstract][Full Text] [Related]
2. Blunted adrenocorticotrophic hormone release during captopril treatment.
Dessì-Fulgheri P; Alagna S; Madeddu P; Glorioso N; Masala A; Rovasio PP; Leoni C; Rappelli A
J Hypertens Suppl; 1985 Nov; 3(2):S125-7. PubMed ID: 3003300
[TBL] [Abstract][Full Text] [Related]
3. Autonomic neural control mechanisms and the release of adrenal steroids after hypoglycaemia in man.
Frier BM; Al-Dujaili EA; Corrall RJ; Pritchard JL; Edwards CR
Horm Metab Res; 1984 Dec; 16 Suppl 1():138-41. PubMed ID: 6099814
[TBL] [Abstract][Full Text] [Related]
4. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.
Morganti A; Grassi G; Sala C; Capozi A; Turolo L; Sabadini E; Bolla G; Mancia G; Zanchetti A
J Hypertens Suppl; 1985 Dec; 3(3):S259-62. PubMed ID: 2856713
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans.
Broglio F; Prodam F; Gottero C; Destefanis S; Me E; Riganti F; Giordano R; Picu A; Balbo M; Van der Lely AJ; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2004 Jun; 60(6):699-704. PubMed ID: 15163333
[TBL] [Abstract][Full Text] [Related]
7. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
[TBL] [Abstract][Full Text] [Related]
9. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
10. Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers.
Troughton RW; Frampton CM; Lewis LK; Yandle TG; Richards AM; Nicholls MG
Clin Sci (Lond); 2001 Jul; 101(1):103-9. PubMed ID: 11410122
[TBL] [Abstract][Full Text] [Related]
11. Blood pressure effects of acute intravenous renin or oral angiotensin converting enzyme inhibition in essential hypertension.
Azizi M; Guyene TT; Chatellier G; Ménard J
J Hypertens; 1994 Apr; 12(4):419-27. PubMed ID: 8064166
[TBL] [Abstract][Full Text] [Related]
12. The effect of captopril on renin, angiotensin II, cortisol and aldosterone during ACTH-infusion in man.
Oelkers W; Belkien L; Baumann J; Meyland M
Clin Exp Hypertens A; 1982; 4(9-10):1505-17. PubMed ID: 6291811
[TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II blockade on the responses of the pituitary-adrenal axis to corticotropin-releasing factor in humans.
Morganti A; Ambrosi B; Sala C; Cianci L; Bochicchio D; Turolo L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S167-9. PubMed ID: 2485058
[TBL] [Abstract][Full Text] [Related]
14. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Erman A; Boner G; van Dijk DJ
J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
[TBL] [Abstract][Full Text] [Related]
15. [Behavior of aldosterone and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterial hypertension].
Tosti-Croce C; Graziosi S; Giaquinto G; Sparano F; Sciarra F
Minerva Med; 1981 Mar; 72(9):575-80. PubMed ID: 6264356
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of captopril on aldosterone secretory responses to endogenous or exogenous adrenocorticotropin.
Ramirez G; Ganguly A; Brueggemeyer CD
J Clin Endocrinol Metab; 1988 Jan; 66(1):46-50. PubMed ID: 2826529
[TBL] [Abstract][Full Text] [Related]
18. [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension].
Morales MA; Carvajal CA; Ortiz E; Mosso LM; Artigas RA; Owen GI; Fardella CE
Rev Med Chil; 2008 Jun; 136(6):701-10. PubMed ID: 18769825
[TBL] [Abstract][Full Text] [Related]
19. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibition reduces ACTH release due to hypoglycaemia.
Glorioso N; Dessì-Fulgheri P; Alagna S; Rubattu S; Soro A; Madeddu P; Bandiera F; Masala A; Rovasio PP; Rappelli A
Clin Exp Hypertens A; 1987; 9(2-3):665-70. PubMed ID: 3038430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
